Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities.

IF 1.3 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiovascular Endocrinology & Metabolism Pub Date : 2020-04-17 eCollection Date: 2020-09-01 DOI:10.1097/XCE.0000000000000199

Dennis Bruemmer, Steven E Nissen

{"title":"Prevention and management of cardiovascular disease in patients with diabetes: current challenges and opportunities.","authors":"Dennis Bruemmer, Steven E Nissen","doi":"10.1097/XCE.0000000000000199","DOIUrl":null,"url":null,"abstract":"<p><p>More than 100 million people in the USA have diabetes or prediabetes and are at high risk for developing cardiovascular disease. Current evidence-based guidelines support a multifactorial approach in patients with diabetes, including lifestyle intervention and pharmacological treatment of hyperglycemia, hypertension, and dyslipidemia. In addition, recent cardiovascular outcome trials demonstrated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. Albeit this evidence, over 80% of patients with diabetes do not achieve the recommended treatment goals. Considering the rising burden of cardiovascular complications, there is need to improve the quality of care in patients with diabetes. In this review, we discuss the current quality of health care in patients with diabetes in the USA, identify barriers to achieve guideline-recommended treatment goals and outline opportunities for the improvement in caring for patients with diabetes.</p>","PeriodicalId":43231,"journal":{"name":"Cardiovascular Endocrinology & Metabolism","volume":"9 3","pages":"81-89"},"PeriodicalIF":1.3000,"publicationDate":"2020-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410032/pdf/xce-9-081.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/XCE.0000000000000199","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/9/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

More than 100 million people in the USA have diabetes or prediabetes and are at high risk for developing cardiovascular disease. Current evidence-based guidelines support a multifactorial approach in patients with diabetes, including lifestyle intervention and pharmacological treatment of hyperglycemia, hypertension, and dyslipidemia. In addition, recent cardiovascular outcome trials demonstrated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists improve cardiovascular outcomes in patients with diabetes. Albeit this evidence, over 80% of patients with diabetes do not achieve the recommended treatment goals. Considering the rising burden of cardiovascular complications, there is need to improve the quality of care in patients with diabetes. In this review, we discuss the current quality of health care in patients with diabetes in the USA, identify barriers to achieve guideline-recommended treatment goals and outline opportunities for the improvement in caring for patients with diabetes.

查看原文本刊更多论文

糖尿病患者心血管疾病的预防和管理：当前的挑战和机遇。

美国有 1 亿多人患有糖尿病或糖尿病前期，是心血管疾病的高危人群。目前的循证指南支持对糖尿病患者采取多因素治疗方法，包括生活方式干预以及高血糖、高血压和血脂异常的药物治疗。此外，最近的心血管结果试验表明，钠-葡萄糖共转运体-2 抑制剂和胰高血糖素样肽 1 受体激动剂可改善糖尿病患者的心血管结果。尽管有这些证据，但仍有超过 80% 的糖尿病患者没有达到推荐的治疗目标。考虑到心血管并发症的负担日益加重，有必要提高糖尿病患者的护理质量。在这篇综述中，我们讨论了美国糖尿病患者目前的医疗质量，找出了实现指南推荐的治疗目标的障碍，并概述了改善糖尿病患者护理的机会。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiovascular Endocrinology & Metabolism CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

5.60

自引率

0.00%

发文量